Nordquist and Johansson Moriwaki Y, Inokuchi T, Yamamoto A, et al. 2007. Effect of TNF-alpha inhibition on urinary albumin excretion in experimental diabetic rats. Acta Diabetol, 44:215–8. Nakamura T, Fukui M, Ebihara I, et al. 1993. mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes, 42:450–6. Navarro JF, Mora C, Maca M, et al. 2003. Inﬂammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. Am J Kidney Dis, 42:53–61. Nordquist L, Moe E, Sjoquist M. 2007. The C-peptide fragment EVARQ reduces glomerular hyperﬁltration in streptozotocin-induced diabetic rats. Diabetes Metab Res Rev, 23:400–5. O’Neill LA, Kaltschmidt C. 1997. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci, 20:252–8. Pieper GM, Riaz-ul-Haq. 1997. Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. J Cardiovasc Pharmacol, 30:528–32. Samnegard B, Jacobson SH, Jaremko G, et al. 2001. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int, 60:1258–65. Samnegard B, Jacobson SH, Johansson BL, et al. 2004. C-peptide and captopril are equally effective in lowering glomerular hyperﬁltration in diabetic rats. Nephrol Dial Transplant, 19:1385–91. Sari R, Balci MK. 2005. Relationship between C peptide and chronic compli- cations in type-2 diabetes mellitus. J Natl Med Assoc, 97:1113–8. Scalia R, Coyle KM, Levine BJ, et al. 2000. C-peptide inhibits leukocyte- endothelium interaction in the microcirculation during acute endothelial dysfunction. FASEB J, 14:2357–64. Schmidt C, Hocherl K, Schweda F, et al. 2007. Regulation of renal sodium transporters during severe inﬂammation. J Am Soc Nephrol, 18:1072–83. Shapiro AM, Ricordi C, Hering BJ, et al. 2006. International trial of the Edmonton protocol for islet transplantation. N Engl J Med, 355:1318–30. Sima AA, Zhang W, Grunberger G. 2004. Type 1 diabetic neuropathy and C-peptide. Exp Diabesity Res, 5:65–77. Sjoquist M, Huang W, Johansson BL. 1998. Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int, 54:758–64. Steffes MW, Sibley S, Jackson M, et al. 2003. Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care, 26:832–6. Stridh S, Sällström J, Fridén M, et al. 2008. C-peptide normalizes glomerular ﬁltration rate in hyperﬁltrating streptozotocin-induced diabetic rats. In vivo measurements in conscious rats. Adv Exp Med Biol, In press. Sugimoto H, Shikata K, Wada J, et al. 1999. Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli. Diabetologia, 42:878–86. Tsimaratos M, Roger F, Chabardes D, et al. 2003. C-peptide stimulates Na+,K+-ATPase activity via PKC alpha in rat medullary thick ascending limb. Diabetologia, 46:124–31. Walcher D, Aleksic M, Jerg V, et al. 2004. C-peptide induces chemotaxis of human CD4-positive cells: involvement of pertussis toxin-sensitive G-proteins and phosphoinositide 3-kinase. Diabetes, 53:1664–70. Walcher D, Babiak C, Poletek P, et al. 2006. C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2. Circ Res, 99:1181–7. Witztum JL, Steinberg D. 1991. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest, 88:1785–92. Yerneni KK, Bai W, Khan BV, et al. 1999. Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes, 48:855–64. Young LH, Ikeda Y, Scalia R, et al. 2000. C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion. Am J Physiol Heart Circ Physiol, 279:H1453–9. Zhong Z, Davidescu A, Ehren I, et al. 2005. C-peptide stimulates ERK1/2 and JNK MAP kinases via activation of protein kinase C in human renal tubular cells. Diabetologia, 48:187–97. Zhong Z, Kotova O, Davidescu A, et al. 2004. C-peptide stimulates Na+, K+–ATPase via activation of ERK1/2 MAP kinases in human renal tubular cells. Cell Mol Life Sci, 61:2782–90. 1288 Vascular Health and Risk Management 2008:4(6)